// App-Quantinova.ai

e20055 : Pulmonary Sarcomatoid Carcinoma with ALK rearrangement: Frequency, Clinical-Pathological Characteristics, and Response to ALK inhibitor.

Researchers

Presenter

  • Xinru Chen

Principal Investigators

  • Jianzhong Liang

  • Jiabin Lu

  • Yu Zhang

  • Chuan-Miao Xie

  • Shaohan Yin

  • Likun Chen

  • Xuewen Liu

Medical Centers

  • Sun Yat-Sen University Cancer Center, Guangdzhou, Guangdong, China

  • Sun Yat-Sen University Cancer Center, Guangdzhou, Guangdong, China

  • Diagnostic Imaging and Intervening Center, Cancer Center, Sun Yat-sen University, Guangzhou, China

  • Sun Yat-Sen University Cancer Center, Guangdzhou, Guangdong, China

  • Cancer Center Sun Yat Sen University, Guangzhou, China

  • Sun Yat-Sen University Cancer Center, Guangdzhou, Guangdong, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pulmonary sarcomatoid carcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Crizotinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved